The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Extended adjuvant tamoxifen for early breast cancer: A meta-analysis.
Eitan Amir
No relevant relationships to disclose
Mustafa Al-Mubarak
No relevant relationships to disclose
Ariadna Tibau
No relevant relationships to disclose
Arnoud J. Templeton
No relevant relationships to disclose
Alberto Ocana
No relevant relationships to disclose
Bostjan Seruga
No relevant relationships to disclose